Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04242875 · ClinicalTrials.gov registry record
The Effects of Angle Kappa on Clinical Outcomes With the PanOptix Intraocular Lens
A clinical trial, sponsored by Carolina Eyecare Physicians.
- Completed
- Registry status
- 30
- Enrollment target
NCT04242875: Completed study, sponsored by Carolina Eyecare Physicians.
NCT04242875 is a clinical trial that has completed, run by Carolina Eyecare Physicians. The registered enrollment target is 30 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04242875 has completed, sponsored by Carolina Eyecare Physicians.
- COMPLETED
- Registry status
- 30 participants
- Enrollment target
Study Summary
Angle Kappa is considered a potential factor in explaining suboptimal outcomes with intraocular lenses (IOLs), particularly multifocal IOLs. Some evidence suggests this is not the case. This study was designed to investigate correlations between angle kappa and post-surgical outcomes with a trifocal IOL.
Primary Outcome
Frequency of visual disturbances with magnitude of Angle Kappa
Interventions
- DIAGNOSTIC_TEST Angle Kappa
- OTHER Visual disturbance questionnaire.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2020-01-21 |
| Est. Completion | 2021-04-27 |
What the finished NCT04242875 record still lists
NCT04242875 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 30 participants, a relatively small participant target.
The record links to 0 conditions, and to 2 interventions - of which Angle Kappa is the first listed.
NCT04242875 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04242875 about?
NCT04242875 is a clinical study titled "The Effects of Angle Kappa on Clinical Outcomes With the PanOptix Intraocular Lens". Angle Kappa is considered a potential factor in explaining suboptimal outcomes with intraocular lenses (IOLs), particularly multifocal IOLs. Some evidence suggests this is not the case. This study was designed to investigate correlations between angle kappa and post-surgical outcomes with a trifocal...
What is the current status of trial NCT04242875?
This trial is currently completed. The enrollment target is 30 participants. The study started on 2020-01-21. Estimated completion is 2021-04-27.
What interventions are being tested in trial NCT04242875?
The interventions under investigation include: Angle Kappa (DIAGNOSTIC_TEST), Visual disturbance questionnaire. (OTHER).
Who is sponsoring clinical trial NCT04242875?
This trial is sponsored by Carolina Eyecare Physicians, which has 11 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00977977 · 30 participants · Phase 2
Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy
- NCT01459107 · 30 participants · Phase 2
Human Upper Extremity Allotransplantation
- NCT01666080 · 30 participants · NA
Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)
- NCT01720836 · 30 participants · Phase 1
Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI